Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.950
0.00 (0.00%)
May 21, 2026, 1:24 PM CET
Elicera Therapeutics AB Employees
Elicera Therapeutics AB had 3 employees as of March 31, 2026. The number of employees increased by 1 or 50.00% since the number was last reported on December 31, 2025.
Employees
3
Change
1
Growth
50.00%
Revenue / Employee
3.55M SEK
Profits / Employee
-4.82M SEK
Market Cap
143.18M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 3 | 1 | 50.00% |
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | 0 | - |
| Dec 31, 2023 | 2 | 0 | - |
| Dec 31, 2022 | 2 | 1 | 100.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 144 |
| Diamyd Medical AB | 41 |
| IRLAB Therapeutics AB | 31 |
| NextCell Pharma AB | 24 |
| Nanologica AB | 19 |
| AcouSort AB | 16 |
| Alligator Bioscience AB | 13 |
| AlzeCure Pharma AB | 10 |
Elicera Therapeutics AB News
- 1 year ago - Elicera Therapeutics AB Transcript: Investor Update - Transcripts